Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes

BACKGROUND: DNA methylation can be used to predict clinical outcomes and improve the classification of tumors. The present study aimed to develop a new lung adenocarcinoma (LUAD) classification system according to the immune cell gene-related methylation sites and to reveal the survival outcomes, cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ruilin, Huang, Xiaoming, Lin, Junqi, Lin, Shaoming, Shen, Guanle, Chen, Wenbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183559/
https://www.ncbi.nlm.nih.gov/pubmed/37197548
http://dx.doi.org/10.21037/jtd-23-494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183559/
https://www.ncbi.nlm.nih.gov/pubmed/37197548
http://dx.doi.org/10.21037/jtd-23-494

Ejemplares similares